Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss

Detalhes bibliográficos
Principais autores:	Schmidt, W, Gough, S, Madsbad, S, Zinman, B, Falahati, A, Toft, A, Sesti, G
Formato:	Conference item
Publicado em:	2009

Registros relacionados

Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c)
por: Gough, S, et al.
Publicado em: (2010)

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: a meta-analysis of the liraglutide clinical trial programme.
por: Zinman, B, et al.
Publicado em: (2012)

Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme
por: Zinman, B, et al.
Publicado em: (2012)

Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes
por: Matthews, DR, et al.
Publicado em: (2008)

The imaging of insulinomas using a radionuclide-labelled molecule of the GLP-1 analogue liraglutide: a new application of liraglutide.
por: Jing Lv, et al.
Publicado em: (2014-01-01)

Reductions in HbA(1c) and the incidence of hypoglycaemic episodes are not affected by renal impairment in patients with type 2 diabetes treated with liraglutide
por: Gough, S, et al.
Publicado em: (2011)

Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline
por: Schmitz, O, et al.
Publicado em: (2008)

Liraglutide More Effectively Achieves a Composite Endpoint for A1C, SBP and Weight Change Than Other Diabetes Therapies
por: Zinman, B, et al.
Publicado em: (2009)

Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model.
por: Vadivel Parthsarathy, et al.
Publicado em: (2013-01-01)

Fructosamine and HbA1c
por: Kurumbian Chandran, et al.
Publicado em: (2024-02-01)

HbA1c: an independent risk factor for dysthyroid optic neuropathy
por: Xing Wang, et al.
Publicado em: (2023-10-01)

HbA1c is Independent Prognostic Factor for Elderly ESRD Patients
por: Soon Hyo Kwon, et al.
Publicado em: (2012-06-01)

Diagnosis of diabetes: HbA1c versus WHO criteria
por: Manley, S, et al.
Publicado em: (2010)

GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway
por: Tao Zhu, et al.
Publicado em: (2018-01-01)

HbA1C and diabetes – an overview
por: S Pathmanathan, et al.
Publicado em: (2014-01-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
por: Alexander Sergeevich Ametov, et al.
Publicado em: (2011-12-01)

The GLP-1 analog liraglutide attenuates acute liver injury in mice
por: Letícia Milani, et al.
Publicado em: (2019-11-01)

The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.
por: Marcus Lind, et al.
Publicado em: (2009-01-01)

Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
por: Susanne Amsberg, et al.
Publicado em: (2023-12-01)

Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone
por: Amit Rastogi, et al.
Publicado em: (2012-01-01)

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
por: Grazia Daniela Femminella, et al.
Publicado em: (2019-04-01)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements.
por: Nasir, N.M., et al.
Publicado em: (2010)

How should HbA(1c) be incorporated into the diagnostic pathway for diabetes mellitus?
por: Manley, SE, et al.
Publicado em: (2010)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
por: Xiaojing Feng, et al.
Publicado em: (2021-05-01)

Protective effect of GLP-1 analog liraglutide on podocytes in mice with diabetic nephropathy
por: Shaomin Shi, et al.
Publicado em: (2023-09-01)

Use of HbA1c in the diagnosis of diabetes.
por: Farmer, A
Publicado em: (2012)

Effects of thyroid status on HbA1c
por: Sivaranjani Ambalavanan, et al.
Publicado em: (2024-11-01)

Drugs affecting HbA1c levels
por: Ranjit Unnikrishnan, et al.
Publicado em: (2012-01-01)

Current Status of HbA1c Biosensors
por: Hua Lin, et al.
Publicado em: (2017-08-01)

Could HbA(1c) have a role in the diagnosis of type 2 diabetes?
por: Manley, SE, et al.
Publicado em: (2007)

Efficacy of Liraglutide: GLP 1 Receptor Agonist on Glycemic Control and Weight Loss among Patients with Type 2 Diabetes
por: Fatima Jehangir, et al.
Publicado em: (2020-01-01)

Achieving glycaemic control and weight loss with incretin-based therapies: a comparison of liraglutide, exenatide, and sitagliptin
por: Zinman, B, et al.
Publicado em: (2011)

HbA1c and height loss among Japanese workers: A retrospective study.
por: Yuji Shimizu, et al.
Publicado em: (2023-01-01)

HbA1c and height loss among Japanese workers: A retrospective study
por: Yuji Shimizu, et al.
Publicado em: (2023-01-01)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Christian Stevns Hansen, et al.
Publicado em: (2019-04-01)

Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet
por: Mads Rosenkilde, et al.
Publicado em: (2019-11-01)

Haemoglobin types and variant interference with HbA1c and its association with uncontrolled HbA1c in type 2 diabetes mellitus
por: Joseph Malaba, et al.
Publicado em: (2024-11-01)

Symposium 3: HbA1c: Are HbA1c determinations reliable enough today in Argentina to adopt them as diagnostic criteria?
por: Carla Lucarelli
Publicado em: (2022-09-01)

Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population
por: Ma Han, et al.
Publicado em: (2013-01-01)

Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes.
por: HaEun Ji, et al.
Publicado em: (2020-01-01)